Firefly Neuroscience, Inc. (NASDAQ:AIFF – Get Free Report) shares were down 2.5% on Wednesday . The stock traded as low as $4.09 and last traded at $4.24. Approximately 379,563 shares were traded during trading, a decline of 89% from the average daily volume of 3,562,011 shares. The stock had previously closed at $4.35.
Firefly Neuroscience Stock Performance
The business’s 50 day simple moving average is $5.06 and its 200-day simple moving average is $3.81.
Institutional Trading of Firefly Neuroscience
A hedge fund recently raised its stake in Firefly Neuroscience stock. Geode Capital Management LLC raised its holdings in Firefly Neuroscience, Inc. (NASDAQ:AIFF – Free Report) by 5.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 60,242 shares of the company’s stock after purchasing an additional 2,884 shares during the quarter. Geode Capital Management LLC owned 0.76% of Firefly Neuroscience worth $160,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 4.96% of the company’s stock.
About Firefly Neuroscience
Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.
Featured Stories
- Five stocks we like better than Firefly Neuroscience
- 3 Warren Buffett Stocks to Buy Now
- Energy Transfer: Powering Data With Dividends and Diversification
- What is Forex and How Does it Work?
- Qualcomm Stock Is Coiling for a Breakout
- How to Use the MarketBeat Excel Dividend Calculator
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Firefly Neuroscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Firefly Neuroscience and related companies with MarketBeat.com's FREE daily email newsletter.